ClariVest Asset Management LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,228
-24.7%
45,736
+0.1%
0.07%
-18.3%
Q2 2023$1,630
+22.3%
45,695
-13.0%
0.08%
+36.7%
Q1 2023$1,333
-37.4%
52,498
+0.1%
0.06%
-41.7%
Q4 2022$2,128
-99.9%
52,466
-0.3%
0.10%
+22.6%
Q3 2022$1,740,000
-20.4%
52,628
-15.3%
0.08%
-11.6%
Q2 2022$2,187,000
-31.5%
62,117
-10.5%
0.10%
-24.6%
Q1 2022$3,193,000
-31.0%
69,427
-0.6%
0.13%
-11.3%
Q4 2021$4,629,000
-2.4%
69,827
-8.1%
0.14%
-7.2%
Q3 2021$4,742,000
-28.1%
75,959
-4.6%
0.15%
-30.5%
Q2 2021$6,596,000
+100.2%
79,649
+60.3%
0.22%
+89.7%
Q1 2021$3,295,000
-15.9%
49,690
-2.7%
0.12%
-12.8%
Q4 2020$3,920,000
+14.1%
51,090
-35.9%
0.13%
+18.8%
Q3 2020$3,435,000
-3.8%
79,752
-3.5%
0.11%
+15.5%
Q2 2020$3,572,000
+52.1%
82,677
+1.3%
0.10%
+38.6%
Q1 2020$2,348,000
-53.6%
81,612
+2.2%
0.07%
-39.7%
Q4 2019$5,063,000
+48.4%
79,837
-34.0%
0.12%
+50.6%
Q3 2019$3,411,000
+5.0%
121,023
-1.3%
0.08%
+5.5%
Q2 2019$3,250,000
+2.5%
122,623
-29.0%
0.07%
+14.1%
Q1 2019$3,170,000
+66.2%
172,723
+12.5%
0.06%
+56.1%
Q4 2018$1,907,000
-14.7%
153,515
+31.7%
0.04%
+2.5%
Q3 2018$2,235,000
+30.1%
116,601
-7.7%
0.04%
+33.3%
Q2 2018$1,718,000
+238.9%
126,312
+79.4%
0.03%
+233.3%
Q1 2018$507,00070,4000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders